Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
CALL
Root
ROOT
$773M
| $3.61M | ﹤0.01% |
+12,772
| New | +$4.22M |
|
4127
CALL
Liberty Global Class A
LBTYA
$3.55B
| $3.61M | ﹤0.01% |
149,100
+22,600
| +18% | +$503K |
|
4128
PUT
US Physical Therapy
USPH
$1.19B
| $3.61M | ﹤0.01% |
30,000
-5,200
| -15% | -$525K |
|
4129
CALL
AeroVironment
AVAV
$9.42B
| $3.61M | ﹤0.01% |
41,500
-6,800
| -14% | -$546K |
|
4130
PUT
CONMED
CNMD
$1.48B
| $3.61M | ﹤0.01% |
+32,200
| New | +$3.05M |
|
4131
CALL
Direxion Daily Small Cap Bear 3x ETF
TZA
$209M
| $3.61M | ﹤0.01% |
6,562
-1,421
| -18% | -$1.21M |
|
|
WBT
4132
CALL
DELISTED
Welbilt, Inc.
WBT
| $3.61M | ﹤0.01% |
273,200
-76,000
| -22% | -$682K |
|
4133
Construction Partners
ROAD
$6.9B
| $3.6M | ﹤0.01% |
123,843
+102,189
| +472% | +$2.44M |
|
4134
Interparfums
IPAR
$3.63B
| $3.6M | ﹤0.01% |
59,580
-15,270
| -20% | -$768K |
|
|
UPH
4135
PUT
DELISTED
UpHealth, Inc.
UPH
| $3.6M | ﹤0.01% |
+32,880
| New | +$3.39M |
|
|
TLND
4136
DELISTED
Talend S.A. American Depositary Shares
TLND
| $3.6M | ﹤0.01% |
93,899
+53,155
| +130% | +$2.09M |
|
4137
PUT
Cerence
CRNC
$379M
| $3.6M | ﹤0.01% |
35,784
-7,716
| -18% | -$575K |
|
4138
RPM International
RPM
$14.3B
| $3.6M | ﹤0.01% |
39,597
-12,615
| -24% | -$1.11M |
|
|
MTSC
4139
DELISTED
MTS Systems Corp
MTSC
| $3.59M | ﹤0.01% |
61,715
-62,133
| -50% | -$2.25M |
|
|
ONC
4140
BeOne Medicines Ltd
ONC
$40.8B
| $3.59M | ﹤0.01% |
13,888
-797
| -5% | -$219K |
|
|
CVGW
4141
DELISTED
Calavo Growers
CVGW
| $3.59M | ﹤0.01% |
51,671
-4,836
| -9% | -$341K |
|
|
FRC
4142
PUT
DELISTED
First Republic Bank
FRC
| $3.58M | ﹤0.01% |
24,400
-44,700
| -65% | -$5.82M |
|
4143
PUT
PetMed Express
PETS
$38.4M
| $3.58M | ﹤0.01% |
111,800
+37,000
| +49% | +$1.14M |
|
4144
CALL
Royalty Pharma
RPRX
$26.3B
| $3.58M | ﹤0.01% |
71,600
+46,900
| +190% | +$1.99M |
|
4145
PUT
Howard Hughes
HHH
$4B
| $3.58M | ﹤0.01% |
47,625
+20,771
| +77% | +$1.39M |
|
4146
Capitol Federal Financial
CFFN
$1.08B
| $3.58M | ﹤0.01% |
286,522
+31,314
| +12% | +$374K |
|
4147
PUT
MKS Inc
MKSI
$21.8B
| $3.58M | ﹤0.01% |
23,800
+11,500
| +93% | +$1.5M |
|
4148
CALL
US Foods
USFD
$23.6B
| $3.58M | ﹤0.01% |
107,500
-7,500
| -7% | -$214K |
|
|
UNIT
4149
Uniti Group
UNIT
$2.42B
| $3.58M | ﹤0.01% |
305,170
+157,468
| +107% | +$1.64M |
|
|
IPHI
4150
PUT
DELISTED
INPHI CORPORATION
IPHI
| $3.58M | ﹤0.01% |
22,300
-32,500
| -59% | -$4.57M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.